Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Sarepta Therapeutics

Sarepta Therapeutics reported $6.32M in Interest Expense on Debt for its fiscal quarter ending in March of 2023.

Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US USD 28.96M 958K
Amgen AMGN:US USD 543M 128M
BioCryst Pharmaceuticals BCRX:US USD 27.4M 938K
Biogen BIIB:US USD 62.5M 7.7M
BioMarin Pharmaceutical BMRN:US USD 3.7M 77K
Eli Lilly LLY:US USD 102.8M 18.8M
Esperion Therapeutics ESPR:US USD 14.39M 58K
Gilead Sciences GILD:US USD 230M 3M
Incyte Corp INCY:US USD 469K 198K
Insmed INSM:US USD 20.08M 3.63M
Intercept Pharmaceuticals ICPT:US USD 2.81M 3K
Ionis Pharmaceuticals IONS:US USD 1.61M 123K
Moderna Inc MRNA:US USD 9M 1000K
Nektar Therapeutics NKTR:US USD 6.4M 796K
Neurocrine Biosciences NBIX:US USD 1.1M 0
Novavax NVAX:US USD 4.32M 285K
Pfizer PFE:US USD 318M 5M
PTC Therapeutics PTCT:US USD 27.33M 1.43M
Regeneron Pharmaceuticals REGN:US USD 18M 600K
Roche Holding ROG:VX CHF 348M 92M
Sarepta Therapeutics SRPT:US USD 6.32M 365K
Vertex Pharmaceuticals VRTX:US USD 11.4M 200K